These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 37324659)

  • 21. Prognostic accuracy of time to sputum culture conversion in predicting cure in extensively drug-resistant tuberculosis patients: a multicentre retrospective observational study.
    Abubakar M; Ahmad N; Atif M; Ahmad I; Wahid A; Khan A; Saleem F; Ghafoor A
    BMC Infect Dis; 2022 Mar; 22(1):204. PubMed ID: 35236307
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence and Factors Associated with Multidrug-Resistant Tuberculosis (MDR-TB) among Presumptive MDR-TB Patients in Tigray Region, Northern Ethiopia.
    Mehari K; Asmelash T; Hailekiros H; Wubayehu T; Godefay H; Araya T; Saravanan M
    Can J Infect Dis Med Microbiol; 2019; 2019():2923549. PubMed ID: 31583034
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Time to sputum culture conversion and its predictors among patients with multidrug-resistant tuberculosis in Hangzhou, China: A retrospective cohort study.
    Li Q; Lu M; Hsieh E; Wu L; Wu Y; Wang M; Wang L; Zhao G; Xie L; Qian HZ
    Medicine (Baltimore); 2020 Dec; 99(50):e23649. PubMed ID: 33327347
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictors of unfavorable responses to therapy in rifampicin-sensitive pulmonary tuberculosis using an integrated approach of radiological presentation and sputum mycobacterial burden.
    Gopalan N; Srinivasalu VA; Chinnayan P; Velayutham B; Bhaskar A; Santhanakrishnan R; Senguttuvan T; Rathinam S; Ayyamperumal M; Satagopan K; Rajendran D; Manoharan T; Lakshmanan S; Paramasivam P; Angamuthu D; Ganesan M; Easudoss Arockia JW; Venkatesan RB; Lakshmipathy V; Shanmugham S; Subramanyam B; Shankar S; Mohideen Shaheed J; Dhanaraj B; Paranji Ramiyengar N; Swaminathan S; Chandrasekaran P
    PLoS One; 2021; 16(9):e0257647. PubMed ID: 34543329
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Xpert MTB/RIF Use Is Associated With Earlier Treatment Initiation and Culture Conversion Among Patients With Sputum Smear-Negative Multidrug-Resistant Tuberculosis.
    Kipiani M; Graciaa DS; Buziashvili M; Darchia L; Avaliani Z; Tabagari N; Mirtskhulava V; Kempker RR
    Open Forum Infect Dis; 2021 Dec; 8(12):ofab551. PubMed ID: 34877367
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diabetes Reduces the Rate of Sputum Culture Conversion in Patients With Newly Diagnosed Multidrug-Resistant Tuberculosis.
    Salindri AD; Kipiani M; Kempker RR; Gandhi NR; Darchia L; Tukvadze N; Blumberg HM; Magee MJ
    Open Forum Infect Dis; 2016 Sep; 3(3):ofw126. PubMed ID: 27419188
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors affecting time to sputum culture conversion and treatment outcome of patients with multidrug-resistant tuberculosis in China.
    Liu Q; Lu P; Martinez L; Yang H; Lu W; Ding X; Zhu L
    BMC Infect Dis; 2018 Mar; 18(1):114. PubMed ID: 29510666
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors associated with culture conversion among adults treated for pulmonary extensively drug-resistant tuberculosis during 2018-2019 in the Russian Federation: an observational cohort study.
    Russkikh A; Korotych O; Sereda Y; Samoilova A; Achar J; Yedilbayev A; Dara M; Vasilyeva I
    Monaldi Arch Chest Dis; 2021 Jan; 91(1):. PubMed ID: 33470087
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between Body Mass Index and Sputum Culture Conversion among South Korean Patients with Multidrug Resistant Tuberculosis in a Tuberculosis Referral Hospital.
    Park HO; Kim SH; Moon SH; Byun JH; Kim JW; Lee CE; Kim JD; Jang IS; Yang JH
    Infect Chemother; 2016 Dec; 48(4):317-323. PubMed ID: 27883374
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Frequency of MTB and rifampicin resistance MTB using Xpert-MTB/RIF assay among adult presumptive tuberculosis patients in Tigray, Northern Ethiopia: A cross sectional study.
    Wasihun AG; Dejene TA; Hailu GG
    PLoS One; 2020; 15(11):e0240361. PubMed ID: 33147218
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sputum bacteriology conversion and treatment outcome of patients with multidrug-resistant tuberculosis.
    Lv L; Li T; Xu K; Shi P; He B; Kong W; Wang J; Sun J
    Infect Drug Resist; 2018; 11():147-154. PubMed ID: 29416359
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence and factors associated with sputum smear non-conversion after two months of tuberculosis treatment among smear-positive pulmonary tuberculosis patients in Rwanda: a cross-sectional study.
    Gatete G; Njunwa KJ; Migambi P; Ntaganira J; Ndagijimana A
    BMC Infect Dis; 2023 Jun; 23(1):408. PubMed ID: 37322426
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characteristics of pulmonary multidrug-resistant tuberculosis patients in Tigray Region, Ethiopia: A cross-sectional study.
    Welekidan LN; Skjerve E; Dejene TA; Gebremichael MW; Brynildsrud O; Agdestein A; Tessema GT; Tønjum T; Yimer SA
    PLoS One; 2020; 15(8):e0236362. PubMed ID: 32797053
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Smear positive pulmonary tuberculosis and associated factors among homeless individuals in Dessie and Debre Birhan towns, Northeast Ethiopia.
    Semunigus T; Tessema B; Eshetie S; Moges F
    Ann Clin Microbiol Antimicrob; 2016 Aug; 15(1):50. PubMed ID: 27581729
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors Affecting Time to Sputum Culture Conversion in Adults with Pulmonary Tuberculosis: A Historical Cohort Study without Censored Cases.
    Kanda R; Nagao T; Tho NV; Ogawa E; Murakami Y; Osawa M; Saika Y; Doi K; Nakano Y
    PLoS One; 2015; 10(11):e0142607. PubMed ID: 26558764
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative effectiveness of individualized longer and standardized shorter regimens in the treatment of multidrug resistant tuberculosis in a high burden country.
    Wahid A; Ghafoor A; Khan AW; Al-Worafi YM; Latif A; Shahwani NA; Atif M; Saleem F; Ahmad N
    Front Pharmacol; 2022; 13():973713. PubMed ID: 36160454
    [No Abstract]   [Full Text] [Related]  

  • 37. Comparison of bacteriological conversion and treatment outcomes among MDR-TB patients with and without diabetes in Mexico: Preliminary data.
    Muñoz-Torrico M; Caminero Luna J; Migliori GB; D'Ambrosio L; Carrillo-Alduenda JL; Villareal-Velarde H; Torres-Cruz A; Flores-Ergara H; Martínez-Mendoza D; García-Sancho C; Centis R; Salazar-Lezama MÁ; Pérez-Padilla R
    Rev Port Pneumol (2006); 2017; 23(1):27-30. PubMed ID: 28043788
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chest radiograph findings and time to culture conversion in patients with multidrug-resistant tuberculosis and HIV in Tugela Ferry, South Africa.
    Brust JC; Berman AR; Zalta B; Haramati LB; Ning Y; Heo M; van der Merwe TL; Bamber S; Moll AP; Friedland GH; Shah NS; Gandhi NR
    PLoS One; 2013; 8(9):e73975. PubMed ID: 24040132
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictors of sputum culture conversion among patients treated for multidrug-resistant tuberculosis.
    Kurbatova EV; Gammino VM; Bayona J; Becerra MC; Danilovitz M; Falzon D; Gelmanova I; Keshavjee S; Leimane V; Mitnick CD; Quelapio MI; Riekstina V; Taylor A; Viiklepp P; Zignol M; Cegielski JP
    Int J Tuberc Lung Dis; 2012 Oct; 16(10):1335-43. PubMed ID: 23107633
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of genotype MTBDRplus VER 2.0 line probe assay for the detection of MDR-TB in smear positive and negative sputum samples.
    Meaza A; Kebede A; Yaregal Z; Dagne Z; Moga S; Yenew B; Diriba G; Molalign H; Tadesse M; Adisse D; Getahun M; Desta K
    BMC Infect Dis; 2017 Apr; 17(1):280. PubMed ID: 28415989
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.